These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 30573125)

  • 1. Asymptomatic Cerebral Infarction During Catheter Ablation for Atrial Fibrillation: Comparing Uninterrupted Rivaroxaban and Warfarin (ASCERTAIN).
    Kimura T; Kashimura S; Nishiyama T; Katsumata Y; Inagawa K; Ikegami Y; Nishiyama N; Fukumoto K; Tanimoto Y; Aizawa Y; Tanimoto K; Fukuda K; Takatsuki S
    JACC Clin Electrophysiol; 2018 Dec; 4(12):1598-1609. PubMed ID: 30573125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility and safety of uninterrupted rivaroxaban for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry.
    Lakkireddy D; Reddy YM; Di Biase L; Vallakati A; Mansour MC; Santangeli P; Gangireddy S; Swarup V; Chalhoub F; Atkins D; Bommana S; Verma A; Sanchez JE; Burkhardt JD; Barrett CD; Baheiry S; Ruskin J; Reddy V; Natale A
    J Am Coll Cardiol; 2014 Mar; 63(10):982-8. PubMed ID: 24412445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial.
    Di Biase L; Burkhardt JD; Santangeli P; Mohanty P; Sanchez JE; Horton R; Gallinghouse GJ; Themistoclakis S; Rossillo A; Lakkireddy D; Reddy M; Hao S; Hongo R; Beheiry S; Zagrodzky J; Rong B; Mohanty S; Elayi CS; Forleo G; Pelargonio G; Narducci ML; Dello Russo A; Casella M; Fassini G; Tondo C; Schweikert RA; Natale A
    Circulation; 2014 Jun; 129(25):2638-44. PubMed ID: 24744272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of uninterrupted rivaroxaban taken preoperatively for radiofrequency catheter ablation of atrial fibrillation compared to uninterrupted warfarin.
    Tao S; Otomo K; Ono Y; Osaka Y; Hirao T; Koura K; Manno T; Ueshima D; Shimizu S; Isobe M; Hirao K
    J Interv Card Electrophysiol; 2017 Mar; 48(2):167-175. PubMed ID: 27943112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of safety and efficacy of periprocedural use of rivaroxaban and apixaban in catheter ablation for atrial fibrillation.
    Yoshimura A; Iriki Y; Ichiki H; Oketani N; Okui H; Maenosono R; Namino F; Miyata M; Ohishi M
    J Cardiol; 2017 Jan; 69(1):228-235. PubMed ID: 27131792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic benefits of rivaroxaban in non-valvular atrial fibrillation patients after radiofrequency catheter ablation.
    Zhu J; Gao RJ; Liu Q; Jiang RH; Yu L; Sun YX; Zhang P; Lin JW; Ye Y; Zhang ZW; Chen SQ; Cheng H; Sheng X; Jiang CY
    J Zhejiang Univ Sci B; 2017 Nov.; 18(11):946-954. PubMed ID: 29119732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apixaban versus Warfarin for the Prevention of Periprocedural Cerebral Thromboembolism in Atrial Fibrillation Ablation: Multicenter Prospective Randomized Study.
    Kuwahara T; Abe M; Yamaki M; Fujieda H; Abe Y; Hashimoto K; Ishiba M; Sakai H; Hishikari K; Takigawa M; Okubo K; Takagi K; Tanaka Y; Nakajima J; Takahashi A
    J Cardiovasc Electrophysiol; 2016 May; 27(5):549-54. PubMed ID: 26766541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periprocedural Management of New Oral Anticoagulants in Atrial Fibrillation Ablation.
    Zak M; Castiblanco SA; Garg J; Palaniswamy C; Jacobs LE
    J Cardiovasc Pharmacol Ther; 2015 Sep; 20(5):457-64. PubMed ID: 25827857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility and safety of uninterrupted periprocedural apixaban administration in patients undergoing radiofrequency catheter ablation for atrial fibrillation: Results from a multicenter study.
    Di Biase L; Lakkireddy D; Trivedi C; Deneke T; Martinek M; Mohanty S; Mohanty P; Prakash S; Bai R; Reddy M; Gianni C; Horton R; Bailey S; Sigmund E; Derndorfer M; Schade A; Mueller P; Szoelloes A; Sanchez J; Al-Ahmad A; Hranitzky P; Gallinghouse GJ; Hongo RH; Beheiry S; Pürerfellner H; Burkhardt JD; Natale A
    Heart Rhythm; 2015 Jun; 12(6):1162-8. PubMed ID: 25728754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation.
    Calkins H; Willems S; Gerstenfeld EP; Verma A; Schilling R; Hohnloser SH; Okumura K; Serota H; Nordaby M; Guiver K; Biss B; Brouwer MA; Grimaldi M;
    N Engl J Med; 2017 Apr; 376(17):1627-1636. PubMed ID: 28317415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation.
    Cappato R; Marchlinski FE; Hohnloser SH; Naccarelli GV; Xiang J; Wilber DJ; Ma CS; Hess S; Wells DS; Juang G; Vijgen J; Hügl BJ; Balasubramaniam R; De Chillou C; Davies DW; Fields LE; Natale A;
    Eur Heart J; 2015 Jul; 36(28):1805-11. PubMed ID: 25975659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Efficacy of Minimally Interrupted Dabigatran vs Uninterrupted Warfarin Therapy in Adults Undergoing Atrial Fibrillation Catheter Ablation: A Randomized Clinical Trial.
    Nogami A; Harada T; Sekiguchi Y; Otani R; Yoshida Y; Yoshida K; Nakano Y; Nuruki N; Nakahara S; Goya M; Origasa H; Kihara Y; Hirao K; Aonuma K;
    JAMA Netw Open; 2019 Apr; 2(4):e191994. PubMed ID: 31002317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of Uninterrupted Low-Intensity Warfarin for Radiofrequency Catheter Ablation of Atrial Fibrillation in the Elderly.
    Xing Y; Xu B; Xu C; Peng F; Yang B; Qiu Y; Sun Y; Wang S; Guo H
    Ann Pharmacother; 2017 Sep; 51(9):735-742. PubMed ID: 28573932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized comparison of two direct oral anticoagulants for patients undergoing cardiac ablation with a contemporary warfarin control arm.
    Yoshimoto I; Iriki Y; Oketani N; Okui H; Ichiki H; Maenosono R; Namino F; Miyata M; Ohishi M
    J Interv Card Electrophysiol; 2021 Apr; 60(3):375-385. PubMed ID: 32318963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uninterrupted direct oral anticoagulants vs. uninterrupted vitamin K antagonists during catheter ablation of non-valvular atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials.
    Romero J; Cerrud-Rodriguez RC; Diaz JC; Michaud GF; Taveras J; Alviz I; Grupposo V; Cerna L; Avendano R; Kumar S; Kirchhof P; Natale A; Di Biase L
    Europace; 2018 Oct; 20(10):1612-1620. PubMed ID: 29982383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of novel oral anticoagulants compared with uninterrupted warfarin for catheter ablation of atrial fibrillation.
    Armbruster HL; Lindsley JP; Moranville MP; Habibi M; Khurram IM; Spragg DD; Berger RD; Calkins H; Marine JE
    Ann Pharmacother; 2015 Mar; 49(3):278-84. PubMed ID: 25515868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does periprocedural anticoagulation management of atrial fibrillation affect the prevalence of silent thromboembolic lesion detected by diffusion cerebral magnetic resonance imaging in patients undergoing radiofrequency atrial fibrillation ablation with open irrigated catheters? Results from a prospective multicenter study.
    Di Biase L; Gaita F; Toso E; Santangeli P; Mohanty P; Rutledge N; Yan X; Mohanty S; Trivedi C; Bai R; Price J; Horton R; Gallinghouse GJ; Beheiry S; Zagrodzky J; Canby R; Leclercq JF; Halimi F; Scaglione M; Cesarani F; Faletti R; Sanchez J; Burkhardt JD; Natale A
    Heart Rhythm; 2014 May; 11(5):791-8. PubMed ID: 24607716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uninterrupted Direct Oral Anticoagulant and Warfarin Administration in Elderly Patients Undergoing Catheter Ablation for Atrial Fibrillation: A Comparison With Younger Patients.
    Yanagisawa S; Inden Y; Fujii A; Ando M; Funabiki J; Murase Y; Takenaka M; Otake N; Ikai Y; Sakamoto Y; Shibata R; Murohara T
    JACC Clin Electrophysiol; 2018 May; 4(5):592-600. PubMed ID: 29798785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is transesophageal echocardiogram mandatory in patients undergoing ablation of atrial fibrillation with uninterrupted novel oral anticoagulants? Results from a prospective multicenter registry.
    Di Biase L; Briceno DF; Trivedi C; Mohanty S; Gianni C; Burkhardt JD; Mohanty P; Bai R; Gunda S; Horton R; Bailey S; Sanchez JE; Al-Ahmad A; Hranitzky P; Gallinghouse GJ; Reddy YM; Zagrodzky J; Hongo R; Beheiry S; Lakkireddy D; Natale A
    Heart Rhythm; 2016 Jun; 13(6):1197-202. PubMed ID: 26994940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of periprocedural anticoagulation strategy on the incidence of new-onset silent cerebral events after radiofrequency catheter ablation of atrial fibrillation.
    Müller P; Halbfass P; Szöllösi A; Dietrich JW; Fochler F; Nentwich K; Roos M; Krug J; Schmitt R; Mügge A; Deneke T
    J Interv Card Electrophysiol; 2016 Sep; 46(3):203-11. PubMed ID: 27020439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.